• No results found

Release characteristics of cardiac proteins after reversible or irreversible myocardial damage

N/A
N/A
Protected

Academic year: 2021

Share "Release characteristics of cardiac proteins after reversible or irreversible myocardial damage"

Copied!
5
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Release characteristics of cardiac proteins after reversible or irreversible myocardial damage

Hessel, M.H.M.

Citation

Hessel, M. H. M. (2008, February 7). Release characteristics of cardiac proteins after reversible or irreversible myocardial damage. Retrieved from

https://hdl.handle.net/1887/12593

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/12593

Note: To cite this publication please use the final published version (if applicable).

(2)

Abbreviations

(3)

Abbreviations

192

Abbreviations

AMI acute myocardial infarction ANP atrial natriuretic peptide BNP brain natriuretic peptide CHF congestive heart failure CK creatine kinase

CO cardiac output

CRT cardiac resynchronization therapy cTnI cardiac troponin I

cTnT cardiac troponin T CVD cardiovascular disease DOG 2-deoxyglucose

ECM extracellular matrix

EDPVR end-diastolic pressure-volume relation EF ejection fraction

ELISA enzyme-linked immunosorbent assay ESPVR end-systolic pressure-volume relation FGF fibroblast growth factor

GAPDH glyceraldehyde-3-phosphate dehydrogenase α-HBDH α-hydroxybutyrate dehydrogenase

HBSS HEPES-buffered salt solution IVS interventricular septum

LDH lactate dehydrogenase LV left ventricle

MCT monocrotaline MHC myosin heavy chain MLC myosin light chain

MMP matrix metalloproteinase NaCN sodium cyanide

NT-proBNP amino-terminal propeptide of brain natriuretic peptide

(4)

PAB pulmonary artery banding PBS phosphate buffered saline PED end-diastolic pressure PES end-systolic pressure RGD Arg-Gly-Asp sequence RGE Asp-Gly-Arg sequence ROS reactive oxygen species RV right ventricle

VED end-diastolic volume VES end-systolic volume

TIMP tissue inhibitor of matrix metalloproteinase TNC tenascin-C

(5)

Abbreviations

194

Referenties

GERELATEERDE DOCUMENTEN

Although cardiac troponins are nowadays the most frequently used biomarkers of irreversible cell damage after AMI, cardiac troponin levels are frequently exceeding the

The main findings of the present study are first, that the release of LDH from necrotic cardiomyocytes precedes that; second, that the quantity of LDH released

was to characterize the release kinetics of intact cTnI, intact cTnT, and degradation products of cTnI and cTnT, in relation to LDH, the golden standard for cell

The purpose of the present study is therefore to investigate whether (1) RGD-induced integrin stimulation causes release of intact and/or fragmented cTnI

We hypothesize that patients with congestive heart failure (CHF) with elevated serum cTnT levels at baseline had myocardial cTnT release due to myocardial

CO and stroke volume were maintained, indicating a compensatory state at the expense of increased RV end-diastolic and end-systolic volumes and increased RV

MCT-induced RV dilatation in rats with heart failure (MCT80) was associated with a significant upregulation of TNC gene expression, resulting in re- expression of

Methods: Clinical parameters, left ventricular (LV) volumes, and circulating levels of tenascin-C (TNC), matrix metalloproteinase-2 (MMP-2), MMP-9, and amino-terminal